Cargando…

Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death

Despite paramount clinical significance of white matter stroke, there is a paucity of researches on the pathomechanism of ischemic white matter damage and accompanying oligodendrocyte (OL) death. Therefore, a large gap exists between clinical needs and laboratory researches in this disease entity. R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jun Young, Kim, Byung Gon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Brain and Neural Science 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597549/ https://www.ncbi.nlm.nih.gov/pubmed/28912641 http://dx.doi.org/10.5607/en.2017.26.4.186

Ejemplares similares

Histamine H(2) receptor negatively regulates oligodendrocyte differentiation in neonatal hypoxic-ischemic white matter injury
por: Jiang, Lei, et al.
Publicado: (2020)

Modeling subcortical ischemic white matter injury in rodents: unmet need for a breakthrough in translational research
por: Cui, Yuexian, et al.
Publicado: (2020)

Oligodendrocyte Development and Implication in Perinatal White Matter Injury
por: Motavaf, Mahsa, et al.
Publicado: (2021)

Toll-like receptors in cerebral ischemic inflammatory injury
por: Wang, Yan-Chun, et al.
Publicado: (2011)

Toll-Like Receptor 3 Expression in Glia and Neurons Alters in Response to White Matter Injury in Preterm Infants
por: Vontell, R., et al.
Publicado: (2013)

Cellular Mechanisms of Toll-Like Receptor-3 Activation in the Thalamus Are Associated With White Matter Injury in the Developing Brain
por: Vontell, Regina, et al.
Publicado: (2015)

Toll-like receptor and its roles in myocardial ischemic/reperfusion injury
por: Fang, Yu, et al.
Publicado: (2011)

Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury
por: van Tilborg, Erik, et al.
Publicado: (2017)

Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Cerebral Ischemic Preconditioning Aggravates Death of Oligodendrocytes
por: Guan, Teng, et al.
Publicado: (2022)

Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury
por: Bohacek, Ivan, et al.
Publicado: (2012)

Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C
por: Huuskonen, Mikko T., et al.
Publicado: (2021)

Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology
por: Li, Jiasi, et al.
Publicado: (2016)

White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes
por: Zhou, Jinyu, et al.
Publicado: (2022)

Ferroptosis in oligodendrocyte progenitor cells mediates white matter injury after hemorrhagic stroke
por: Shen, Danmin, et al.
Publicado: (2022)

Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats
por: Yang, Xinglong, et al.
Publicado: (2018)

The pathophysiology of ischemic injury to developing white matter
por: Alix, James J. P.
Publicado: (2006)

Toll-Like Receptor Evolution: Does Temperature Matter?
por: Sousa, Cármen, et al.
Publicado: (2022)

25.1 OLIGODENDROCYTE PATHOLOGY IN PREFRONTAL WHITE MATTER IN SCHIZOPHRENIA
por: Uranova, Natalya, et al.
Publicado: (2018)

Molecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases
por: Ohtomo, Ryo, et al.
Publicado: (2018)

Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility
por: Larson, Valerie A, et al.
Publicado: (2018)

White-matter repair: Interaction between oligodendrocytes and the neurovascular unit
por: Hamanaka, Gen, et al.
Publicado: (2018)

An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors
por: Dean, Justin M, et al.
Publicado: (2011)

Endothelin-1–Endothelin receptor B complex contributes to oligodendrocyte differentiation and myelin deficits during preterm white matter injury
por: Du, Mengjie, et al.
Publicado: (2023)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
por: McCormack, William, et al.
Publicado: (2012)

Neurotransmitter receptors in the life and death of oligodendrocytes
por: Káradóttir, R., et al.
Publicado: (2007)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

10.2 REDOX DYSREGULATION, OLIGODENDROCYTES AND WHITE MATTER ALTERATIONS IN SCHIZOPHRENIA
por: Klauser, Paul, et al.
Publicado: (2018)

White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
por: Nasrabady, Sara E., et al.
Publicado: (2018)

Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia
por: Uranova, Natalya A., et al.
Publicado: (2018)

Premature axon-oligodendrocyte interaction contributes to stalling of experimental axon regeneration after injury to the white matter
por: Trakhtenberg, Ephraim F.
Publicado: (2023)

Oligodendrocyte Progenitor Cell Transplantation Ameliorates Preterm Infant Cerebral White Matter Injury in Rats Model
por: Wang, Zhaoyan, et al.
Publicado: (2023)

Toll-Like Receptors, Tissue Injury, and Tumourigenesis
por: Ioannou, Savvas, et al.
Publicado: (2010)

Toll-Like Receptors in Acute Kidney Injury
por: Vázquez-Carballo, Cristina, et al.
Publicado: (2021)

Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019)

Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination
por: Leonetti, Camille, et al.
Publicado: (2017)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rcsp5nagi40ouc5a12m6bp4o33